152 related articles for article (PubMed ID: 10391422)
1. A urine metabolic ratio of dextromethorphan and 3-methoxymorphinan as a probe for CYP3A activity and prediction of cyclosporine clearance in healthy volunteers.
Min DI; Ku YM; Vichiendilokkul A; Fleckenstein LL
Pharmacotherapy; 1999 Jun; 19(6):753-9. PubMed ID: 10391422
[TBL] [Abstract][Full Text] [Related]
2. Single-point plasma or urine dextromethorphan method for determining CYP3A activity.
Kuo BP; Hu OY; Hsiong CH; Pao LH; Chen TS; Hung CF
Biopharm Drug Dispos; 2003 Dec; 24(9):367-73. PubMed ID: 14689465
[TBL] [Abstract][Full Text] [Related]
3. Determination of cytochrome P450 3A4/5 activity in vivo with dextromethorphan N-demethylation.
Jones DR; Gorski JC; Haehner BD; O'Mara EM; Hall SD
Clin Pharmacol Ther; 1996 Oct; 60(4):374-84. PubMed ID: 8873685
[TBL] [Abstract][Full Text] [Related]
4. In vivo comparison of putative probes of CYP3A4/5 activity: erythromycin, dextromethorphan, and verapamil.
Krecic-Shepard ME; Barnas CR; Slimko J; Gorski JC; Wainer IW; Schwartz JB
Clin Pharmacol Ther; 1999 Jul; 66(1):40-50. PubMed ID: 10430108
[TBL] [Abstract][Full Text] [Related]
5. Comparative contribution to dextromethorphan metabolism by cytochrome P450 isoforms in vitro: can dextromethorphan be used as a dual probe for both CTP2D6 and CYP3A activities?
Yu A; Haining RL
Drug Metab Dispos; 2001 Nov; 29(11):1514-20. PubMed ID: 11602530
[TBL] [Abstract][Full Text] [Related]
6. Dextromethorphan as an in vivo probe for the simultaneous determination of CYP2D6 and CYP3A activity.
Ducharme J; Abdullah S; Wainer IW
J Chromatogr B Biomed Appl; 1996 Mar; 678(1):113-28. PubMed ID: 8861661
[TBL] [Abstract][Full Text] [Related]
7. Limitations of dextromethorphan N-demethylation as a measure of CYP3A activity.
Kashuba AD; Nafziger AN; Kearns GL; Leeder JS; Gotschall R; Gaedigk A; Bertino JS
Pharmacogenetics; 1999 Aug; 9(4):453-62. PubMed ID: 10780265
[TBL] [Abstract][Full Text] [Related]
8. Intra-individual variability and influence of urine collection period on dextromethorphan metabolic ratios in healthy subjects.
Chládek J; Zimová G; Martínková J; Tůma I
Fundam Clin Pharmacol; 1999; 13(4):508-15. PubMed ID: 10456294
[TBL] [Abstract][Full Text] [Related]
9. Prediction of cyclosporine clearance in liver transplant recipients by the use of midazolam as a cytochrome P450 3A probe.
Villeneuve JP; L'Ecuyer L; De Maeght S; Bannon P
Clin Pharmacol Ther; 2000 Mar; 67(3):242-8. PubMed ID: 10741627
[TBL] [Abstract][Full Text] [Related]
10. Assessment of CYP2D6 and CYP2C19 activity in vivo in humans: a cocktail study with dextromethorphan and chloroguanide alone and in combination.
Tennezé L; Verstuyft C; Becquemont L; Poirier JM; Wilkinson GR; Funck-Brentano C
Clin Pharmacol Ther; 1999 Dec; 66(6):582-8. PubMed ID: 10613613
[TBL] [Abstract][Full Text] [Related]
11. The effect of grapefruit juice and seville orange juice on the pharmacokinetics of dextromethorphan: the role of gut CYP3A and P-glycoprotein.
Di Marco MP; Edwards DJ; Wainer IW; Ducharme MP
Life Sci; 2002 Jul; 71(10):1149-60. PubMed ID: 12095536
[TBL] [Abstract][Full Text] [Related]
12. A sensitive LC-MS/MS assay for the determination of dextromethorphan and metabolites in human urine--application for drug interaction studies assessing potential CYP3A and CYP2D6 inhibition.
Vengurlekar SS; Heitkamp J; McCush F; Velagaleti PR; Brisson JH; Bramer SL
J Pharm Biomed Anal; 2002 Aug; 30(1):113-24. PubMed ID: 12151071
[TBL] [Abstract][Full Text] [Related]
13. Comparative bioavailability of the microemulsion formulation of cyclosporine (Neoral) with a generic dispersion formulation (Cicloral) in young healthy male volunteers.
Kees F; Bucher M; Schweda F; Gschaidmeier H; Burhenne J; Mikus G; Faerber L
Ther Drug Monit; 2006 Jun; 28(3):312-20. PubMed ID: 16778713
[TBL] [Abstract][Full Text] [Related]
14. Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail".
Streetman DS; Bleakley JF; Kim JS; Nafziger AN; Leeder JS; Gaedigk A; Gotschall R; Kearns GL; Bertino JS
Clin Pharmacol Ther; 2000 Oct; 68(4):375-83. PubMed ID: 11061577
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of factors to decrease bioavailability of cyclosporin A in rats with gentamicin-induced acute renal failure.
Shibata N; Inoue Y; Fukumoto K; Nishimura A; Fukushima K; Yoshikawa Y; Spiteller G; Takada K
Biol Pharm Bull; 2004 Mar; 27(3):384-91. PubMed ID: 14993807
[TBL] [Abstract][Full Text] [Related]
16. Can oral midazolam predict oral cyclosporine disposition?
Paine MF; Davis CL; Shen DD; Marsh CL; Raisys VA; Thummel KE
Eur J Pharm Sci; 2000 Nov; 12(1):51-62. PubMed ID: 11121733
[TBL] [Abstract][Full Text] [Related]
17. Lack of gender differences and large intrasubject variability in cytochrome P450 activity measured by phenotyping with dextromethorphan.
McCune JS; Lindley C; Decker JL; Williamson KM; Meadowcroft AM; Graff D; Sawyer WT; Blough DK; Pieper JA
J Clin Pharmacol; 2001 Jul; 41(7):723-31. PubMed ID: 11452704
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of dextromethorphan N-demethylation activity as a biomarker for cytochrome P450 3A activity in man.
Kawashima Y; Hagiwara M; Inoue Y; Someya T
Pharmacol Toxicol; 2002 Feb; 90(2):82-8. PubMed ID: 12071430
[TBL] [Abstract][Full Text] [Related]
19. In-vivo indices of CYP2D6 activity: comparison of dextromethorphan metabolic ratios in 4-h urine and 3-h plasma.
Chládek J; Zimová G; Beránek M; Martínková J
Eur J Clin Pharmacol; 2000 Dec; 56(9-10):651-7. PubMed ID: 11214771
[TBL] [Abstract][Full Text] [Related]
20. High-performance liquid chromatography assay for simultaneous determination of dextromethorphan and its main metabolites in urine and in microsomal preparations.
Bendriss EK; Markoglou N; Wainer IW
J Chromatogr B Biomed Sci Appl; 2001 Apr; 754(1):209-15. PubMed ID: 11318417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]